SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...
The drug does not completely prevent reactions, but it can reduce the risks posed by trace amounts of food allergens. By Roni Caryn Rabin The Food and Drug Administration approved a drug this month ...
XOLAIR is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks. In people with asthma, CRSwNP and food allergy, a blood test for a substance called IgE must be ...
The U.S. Food and Drug Administration (FDA) has approved a medication for use in treating severe food allergies, and the agency says that this injection is the first of its kind. The drug, which has ...
CHICAGO (WLS) -- After the FDA approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods, sufferers say they're ...
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug ...
Add Yahoo as a preferred source to see more of our stories on Google. The injection is the first of its kind. Getty The U.S. Food and Drug Administration (FDA) has approved a medication for use in ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A medication used to treat asthma can now be ...
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate ...
FILE - This Feb. 20, 2015 photo shows an arrangement of peanuts in New York. Xolair, the brand name for the drug omalizumab, used to treat asthma can now be used to help people with food allergies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results